drugset / Trial / NCT05817201
Toripalimab Plus Radiotherapy for Elderly Esophageal Cancer Patients Treated With Non-chemotherapy Strategy
RandomizedParallel-groupOpen-labelTreatment
Summary
The goal of this clinical trial is to explore the therapeutic efficacy of immune checkpoint inhibitors combined with radical radiotherapy in elderly patients with esophageal cancer.
Timeline
- Start
- 2022-07-01
- Primary completion
- 2023-12-31
- Completion
- 2024-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | S-1 | Small molecule | 70 mg/m2 | — |
| Subject | Toripalimab | Monoclonal antibody | 240 mg | — |